MONMOUTH JUNCTION, N.J., Aug. 18, 2022 /PRNewswire/ — Tris Pharma, Inc. (“Tris”) a fully integrated pharmaceutical company with a robust portfolio of CNS products announced today the decision by the US District Court for the District of New Jersey to uphold the validity of various…

Generated by Feedzy